Medication info
Amlojet Tablets 10/20/10 mg (Amlodipine, Rosuvastatin, Ezetimibe)

Amlojet Tablets 10/20/10 mg (Amlodipine, Rosuvastatin, Ezetimibe)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tabletAmlodipine Besylate›13.889mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pink, biconvex, round film-coated tablets
Packaging
Bottle packaged - 30 tablets/bottle, Bottle packaged - 100 tablets/bottle
Approval status
Active

MFDS item code 202402806 · Approved 2024.11.27

Summary

Main use
Treatment of hypertension and dyslipidemia, relief of angina, and reduction of related risks of hospitalization and procedures
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of amlodipine and the ezetimibe/rosuvastatin combination. Swallow this medicine whole; do not chew, divide, or crush it. Patients taking amlodipine and the ezetimibe/rosuvastatin combination concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ○ Amlodipine <Adults> Administer amlodipine 5mg orally once daily; the dose may be increased up to a maximum of 10 mg daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ○ Ezetimibe/rosuvastatin The ezetimibe/rosuvastatin combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the ezetimibe/rosuvastatin combination. The dose of the ezetimibe/rosuvastatin combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of the ezetimibe/rosuvastatin combination is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the ezetimibe/rosuvastatin combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg once daily.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia, relief of angina, and reduction of related risks of hospitalization and procedures

  • Hypertension
  • fixed occlusion of coronary arteries
  • vascular spasms
  • vasoconstriction
  • myocardial ischemia
  • primary hypercholesterolemia
  • elevated total cholesterol
  • LDL cholesterol
  • Apo B proteins
  • triglycerides
  • and non-HDL cholesterol
View approved original text

This medication is used for patients who need to take Amlodipine and Ezetimibe/Rosuvastatin together. Amlodipine is used to treat hypertension and stable or variant angina due to myocardial ischemia, and it helps reduce the risk of hospitalization due to angina and the risk of coronary angioplasty. Ezetimibe/Rosuvastatin is used to lower total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol while increasing HDL cholesterol levels in patients with primary hypercholesterolemia and heterozygous familial or non-familial dyslipidemia, thus improving blood lipid concentrations. Therefore, this medication is effective in improving cardiovascular health and reducing the risk of related diseases.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of amlodipine and the ezetimibe/rosuvastatin combination. Swallow this medicine whole; do not chew, divide, or crush it. Patients taking amlodipine and the ezetimibe/rosuvastatin combination concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ○ Amlodipine <Adults> Administer amlodipine 5mg orally once daily; the dose may be increased up to a maximum of 10 mg daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ○ Ezetimibe/rosuvastatin The ezetimibe/rosuvastatin combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the ezetimibe/rosuvastatin combination. The dose of the ezetimibe/rosuvastatin combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of the ezetimibe/rosuvastatin combination is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the ezetimibe/rosuvastatin combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg once daily.

Precautions

This medication may rarely cause rhabdomyolysis due to the Rosuvastatin component, leading to a risk of acute renal failure. Therefore, patients exhibiting serious myopathy symptoms or those with risk factors such as severe infections, hypotension, major surgery, trauma, endocrine and electrolyte disorders, or uncontrolled seizures should temporarily discontinue or stop using this medication. Patients with allergies to this medication's ingredients or similar medications, pregnant or potentially pregnant women, nursing mothers, patients with severe liver dysfunction, active liver disease, severe aortic stenosis, muscle disorder patients, those taking cyclosporine, and patients with severe kidney impairment should not use this medication. Patients at high risk for myopathy or rhabdomyolysis, such as those with moderate to severe kidney impairment, hypothyroidism, a history of genetic muscle disease, a history of muscle toxicity due to statins or fibrates, alcohol dependence, and patients of Asian descent should use this medication with caution, and muscle-related tests should be conducted as necessary. This medication can affect liver function, thus regular liver function tests should be performed before and during treatment, and if liver damage symptoms appear, use should be immediately discontinued. Symptoms such as muscle pain, muscle cramping, or muscle weakness may occur; if these symptoms develop, consult a physician immediately. This medication should not be used during pregnancy or breastfeeding, and women of childbearing potential should use appropriate contraception. Elderly patients or those with kidney impairment should be monitored closely due to a higher risk of myopathy. This medication may interact with several other medications; therefore, if taking other medications, it is essential to inform the doctor or pharmacist, particularly when used in conjunction with fibrates, cyclosporine, warfarin, certain antibiotics, etc. In case of overdose, symptoms such as low blood pressure or decreased cardiac function may occur; immediate medical attention should be sought.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, increased alanine aminotransferase, increased aspartate aminotransferase, chest pain, swelling, generalized edema, headache, upper respiratory infection, back pain, dyspnea, acute myocardial infarction, abdominal pain, insomnia, skin tumors, congestion, flushing, fatigue, edema, palpitations, dizziness, drowsiness, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, increased tension, sensory loss, dysesthesia, peripheral neuropathy, syncope, dysgeusia, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, lumbar pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, cough, hair loss, hyperhidrosis, purpura, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary disorders, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, angioedema, erythema multiforme, arrhythmia, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, erythematous skin lesions, papular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, angioedema, hypersensitivity reactions, diabetes, dizziness, constipation, nausea, pruritus, rash, urticaria, myopathy, myositis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia, drug reaction with systemic symptoms syndrome, drug-induced lichenoid eruption, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, memory decline, forgetfulness, amnesia, memory dysfunction, confusion, chest pain, chest discomfort, weakness, generalized edema, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, phlegm, runny nose, limb pain, urticaria, rash, pruritus, conjunctival injection, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests, non-cardiogenic pulmonary edema, hypotension, reflex tachycardia, shock, ventricular spasm

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it is best to store the medicine at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

Pink, biconvex, round film-coated tablets

Package unit

Bottle packaged - 30 tablets/bottle, Bottle packaged - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.